Detalhe da pesquisa
1.
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors.
J Cancer Res Clin Oncol
; 150(2): 99, 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383923
2.
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer.
In Vivo
; 37(5): 2229-2236, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652490
3.
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Anticancer Res
; 41(5): 2597-2603, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33952489
4.
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.
Anticancer Res
; 40(4): 2209-2217, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234916
5.
The Role of Airway and Endobronchial Ultrasound in Perioperative Medicine.
Biomed Res Int
; 2015: 754626, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26788507